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Introduction
The brain is a highly metabolic organ requiring a consistent supply 
of oxygen and nutrients for normal function. Ensuring a sufficient 
oxygen and nutrition supply to the brain is accomplished by highly 
organized cerebral microvascular networks (1). In humans, the cere-
bral microvasculature consists of approximately 400 miles of capil-
laries, and the number of endothelial cells in the brain is similar to 
that of neurons (2). More importantly, there is growing evidence that 
impairment of cerebral microvascular perfusion plays a key role in 
the development of aging-related neurodegenerative diseases (3). 
The aging process is accompanied by increased oxidative stress in 
multiple organs and is a major risk factor for cardiovascular diseases 
(4). Recently, there is growing interest in life stress and local overpro-
duction of angiotensin II (Ang II) in the brain leading to CNS oxida-
tive stress and cerebral vascular damage (5, 6). Abnormal upregula-
tion of brain Ang II activity has also been observed in animal models 
of aging, menopause, and chronic cerebral hypoperfusion (5–7). Ang 
II is a potent activator of endothelial Nox2-NADPH oxidase (Nox2).
The NADPH oxidases consists of a cytochrome b558 (containing 
a catalytic Nox subunit and a p22phox subunit) and several regula-
tory subunits, e.g., p40phox, p47phox, p67phox, and rac1 (8). To date, 
7 isoforms of Nox (Nox1–5 and Duox 1–2) have been discovered 
(9, 10). Among them, Nox2 is highly expressed in cells throughout 
the CNS, including cerebral endothelial cells. Endothelial Nox2 
NADPH oxidase has low basal activity under physiological condi-
tions but is activated by stimuli such as Ang II, high glucose, and 
oxidized LDL. Excessive O2•– production by Nox2 causes endothe-
lial dysfunction, which is involved in the development of many 
vascular diseases, including hypertension, stroke, and cerebral 
small vessel diseases (11). Endothelial dysfunction characterized 
by increased ROS production by Nox2 has been recognized as 
an early feature of aging-related vascular disorders (4, 12, 13). In 
aging mice, Nox2-derived ROS has been shown to damage endo-
thelium-dependent vessel relaxation (4), and transgenic mice with 
endothelial cell-specific Nox2 overexpression display high levels of 
ROS production and ERK1/2 activation in the aorta, with increased 
susceptibility to Ang II–induced dissection (14, 15). Knockout of 
Nox2 protects animals from noise- and sleep deprivation–induced 
endothelial dysfunction and cerebral oxidative stress (16). There 
is a close relationship between the levels of endothelial oxida-
tive stress and the degree of vascular disorders found in experi-
mental animals and in humans (11, 16, 17). However, in normal 
aging- associated brain oxidative stress, cerebral microvascular 
rarefaction, and neuronal degeneration, the mechanism of Nox2 
activation in the brain remains unclear.
In this study, we used littermates of age-matched WT and 
Nox2-knockout (Nox2KO) mice at young (3–4 months; similar to 
humans at 20–30 years of age) and old age (20–22 months; similar 
to humans at 70–80 years) to investigate the mechanism of Nox2 
activation in oxidative damage of the cerebral microvasculature 
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slightly lower ROS production as compared with age-matched WT 
controls (Figure 2A). In comparison to young WT controls, aging 
WT brains displayed a remarkable increase (~2.5-fold) in ROS pro-
duction, and this could be reduced to the levels in young controls 
by addition of Tiron, an O2•– scavenger. The levels of ROS produc-
tion in aging Nox2KO brains were also increased in comparison to 
young Nox2KO brains, albeit to a considerably lesser extent than 
in aging WT brains (Figure 2A, right panels).
We then examined cerebral capillary density (Figure 2B) 
labeled with Lycopersicon esculentum lectin (LE-lectin, specific 
for N-acetyl-d-glucosamine and N-acetyl-polylactosamine oligo-
mers), which has been reported to be an effective and versatile 
endothelial marker of vessels in the CNS (18). For determina-
tion of neuronal density (Figure 2C), sections of the same brain 
regions were labeled with the neuron marker NeuN. We found that 
increased ROS production by aging WT brains was accompanied 
by a significant reduction in cerebral capillary density (Figure 2B) 
and neurons (Figure 2C) in comparison to their respective young 
controls. However, capillary density and neuronal density were 
well preserved in aging Nox2KO brain as compared with young 
Nox2KO controls. Neuronal function was examined by measur-
ing neuron firing frequency in the VTA with or without AMPA 
(2-amino -3-[3-hydroxy-5-methyl-isoxazol-4-yl]propanoic acid), a 
specific agonist of the AMPA receptor responsible for fast synaptic 
transmission in the CNS (19). A representative real-time recording 
of Nox2KO young brain neuron firing is shown in Supplemental 
Figure 3. There was no significant difference in either basal (with-
out AMPA) or AMPA-stimulated neuron firing frequencies between 
young WT and Nox2KO mice (Figure 2D). However, at old age, the 
neuron firing frequency (both basal and AMPA- stimulated) was 
remarkably reduced in aging WT brains but well preserved in aging 
Nox2KO mice (Figure 2D).
Nox2 subunit expression and activation of stress signaling path-
ways in aging brains. Levels of Nox2 subunit expression in the mid-
brain tissue homogenates were examined by Western blotting 
(Figure 3A). Compared with young WT young brains, there were 
significant increases in the protein expression of Nox2 and its reg-
ulatory subunits, i.e., p22phox, p47phox, p67phox, and rac1; and these 
were accompanied by a significant decrease in Nox4 expression 
in aging WT brains. However, in the absence of Nox2, there was 
no significant difference in the levels of expressions of p47phox, 
p67phox, and rac1 between young and aging Nox2KO brains. In 
addition, aging Nox2KO brains had a significant increase in Nox4 
and p22phox expression as compared with their young controls 
(Figure 3A). There was no significant difference in the levels of 
Nox1 and p40phox expression between WT and Nox2KO brains for 
both the young and aging groups. Phosphorylation of p47phox (a 
key regulatory subunit of Nox2) by PKC is a crucial step in Nox2 
activation. Myristoylated alanine-rich protein kinase C substrate 
(MARCKS) phosphorylation is a marker of PKC activation in the 
nervous system (20). We found significant increases in the levels 
of p47phox and MARCKS phosphorylation in aging WT (but not 
Nox2KO) brains (Figure 3B).
MAPK activation is a crucial pathway for Nox2 signaling. 
Therefore, we examined ERK1/2, p38 MAPK, and JNK phos-
phorylation in midbrain tissues. Total levels of the same pro-
tein detected in the same samples were used as loading controls 
and locomotor function in aging. Furthermore, we used a mouse 
model of endothelial cell–specific overexpression of human Nox2–
transgenic (HuNox2Tg) mice to examine whether endothelial Nox2 
activation plays a role in triggering whole brain oxidative stress and 
DNA damage in aging. The clinical significance of aging- associated 
Nox2 activation in brain oxidative stress and cerebral vascular dam-
age was examined using postmortem midbrain tissue samples from 
young (aged 25–38 years) and elderly (aged 61–85 years) adults. The 
signaling pathways of Ang II–induced endothelial Nox2 activation 
and capillary damage were further investigated using primary brain 
microvascular endothelial cells (BMECs) isolated from middle-aged 
WT mice in the presence or absence of specific peptide Nox2 inhib-
itors (Nox2tat). Our study reveals a crucial role for aging-associated 
brain Nox2 activation in oxidative damage of cerebral vasculature 
and neurons, with a key role for endothelial cells.
Results
Knockout of Nox2 improved global metabolism and preserved loco-
motor function at old age. At young age (3–4 months), there was no 
significant difference in body weight, BP, fasting serum glucose, 
insulin, or LDL between WT and Nox2KO mice (Figure 1A). At old 
age (20–22 months), WT mice had significant increases in body 
weight, BP, and levels of fasting glucose, insulin, and LDL. Aging 
WT mice were insulin resistant, as indicated by homeostatic model 
assessment–insulin resistance (HOMA-IR) scores. However, these 
age-related metabolic disorders were reduced or absent in aging 
Nox2KO mice (Figure 1A and Supplemental Figure 1; supplemental 
material available online with this article; https://doi.org/10.1172/
JCI125173DS1).
Locomotor function was examined using motility chambers by 
measuring the horizontal and vertical activity of mice for a period of 
42 hours (the initial 6 hours of establishment period was excluded). 
A clear diurnal locomotor pattern was shown (Figure 1B). Activity 
was low in the daytime and increased markedly at night, starting 
slightly before the expected gradual dimming of the light; and after 
the high initial activity, the activity of the mice decreased until the 
end of the light, “resting” phase. At young age, there was no signif-
icant difference in locomotor activities between WT and Nox2KO 
mice; however, at old age, WT mice (but not Nox2KO mice) had 
notably reduced night horizontal activities (dark period) as com-
pared with young controls (Figure 1B). There was no significant 
difference in vertical movement activities between aging WT and 
No2KO mice (Supplemental Figure 2, A–C). There was no signifi-
cant difference in brain weights between WT and Nox2KO mice 
for either the young or aging group (Supplemental Figure 2D). Vol-
untary running wheel activity was examined during a period of 10 
days (Figure 1C). Once again, there was no significant difference 
between WT and Nox2KO mice at young age. However, there was 
a significant reduction in running wheel activity for aging WT (but 
not Nox2KO) mice in comparison to their respective young controls.
Nox2 activation and oxidative damage of cerebral microvascula-
ture and neurons in aging. In order to establish the role of Nox2- 
derived ROS in aging-associated decline of motor performance 
shown in Figure 1, B and C, we used sections from the midbrain 
region (containing the hippocampus and ventral tegmental area 
[VTA]) to examine in situ ROS production by dihydroethidium 
(DHE) fluorescence (Figure 2A). At young age, Nox2KO brains had 
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there were significant increases in markers of DNA damage, 
i.e., increased phosphorylation of the histone variant H2AX at 
Ser139 to form γH2AX and increased p53 expression in aging 
WT brains. In contrast, there was no significant difference in 
(Figure 3C). Compared with those in young WT brains, levels 
of ERK1/2 and JNK phosphorylation were increased, whereas 
levels of p38 MAPK phosphorylation were decreased in aging 
WT brains. Along with the activation of ERK1/2 and JNK, 
Figure 1. Metabolism and locomotor activities of WT and Nox2KO mice. (A) Metabolic measurements. SBP, systolic BP. (B) Locomotor horizontal 
activity measured using motility chambers. Data were collected in 30-minute bins over a 42-hour period. Total activities were calculated and expressed 
as percent relative to the values of young WT mice (100%). (C) Voluntary running wheel activity measured for 10 days. Average daily activity was calcu-
lated and expressed as percent relative to the values of young WT mice (100%). n = 9 mice. *P < 0.05 for indicated values versus young WT value; †P < 
0.05 for indicated values versus aging WT values. Statistical analysis was performed using 1-way ANOVA followed by Bonferroni’s post hoc tests.
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aging WT brain tissues was further confirmed by increased lipid per-
oxidation detected by MDA assay (Figure 4C) and SOD- inhibitable 
cytochrome c reduction assay (Figure 4D). Although levels of H2O2 
production detected by Amplex red assay were increased for both 
aging WT and aging Nox2KO mice (Figure 4E), in the presence of 
Nox2tat (10 μm/L), the levels of H2O2 produced by aging WT brain 
were notably inhibited. Along with the increased ROS production in 
aging WT brains, there were increases in the levels of brain tissue 
Ang II (Figure 4F) and the expression of a vascular inflammation 
marker (VCAM-1) (Figure 4G). Together, our data strongly suggest a 
crucial role of Nox2-derived O2•– in oxidative damage of the cerebral 
vasculature and neurons in the midbrain region of aging WT mice.
MAPK phosphorylation between young and aging Nox2KO 
brains, and aging Nox2KO brains had less DNA damage as com-
pared with aging WT brains (Figure 3C).
Along with Nox2 activation, there were significant (2-fold) 
increases in NADPH-dependent O2•– production by aging WT (but 
not Nox2KO) brains in comparison to young WT controls as exam-
ined by lucigenin chemiluminescence (Figure 4A). Increased O2•– 
production by the aging WT brains could be significantly reduced by 
adding Tiron, diphenyleneiodonium (DPI; a flavoprotein inhibitor), 
apocynin (a Nox2 inhibitor), or l-NAME (an eNOS inhibitor), but not 
rotenone (mitochondrial complex I enzyme inhibitor) or oxypurinol 
(xanthine oxidase inhibitor) (Figure 4B). Increased ROS production by 
Figure 2. Aging-related chang-
es in WT and Nox2KO mouse 
midbrains. (A) ROS production by 
mouse midbrain sections detected 
by DHE fluorescence. Tiron was 
used to confirm the detection of 
O2
•–. *P < 0.05 for indicated values 
versus young DHE values; †P < 
0.05 for indicated values versus 
DHE values in the same age group. 
Fluo-intensity, fluorescence inten-
sity. (B) Cerebral microvascular 
density. Capillaries were labeled 
with LE-lectin (FITC, green) and 
quantified. (C) Neuronal density. 
Neurons were labeled with NeuN 
(Cy3, red) and quantified. Nuclei 
were labeled with DAPI (blue in 
B and C). n = 6 mice/per group. 
Scale bars: 100 μm. (D) Dopami-
nergic neuron firing frequency. Left 
panels: Representative recording 
traces of aging brains. Right pan-
els: Statistical analysis. n = 14 cells 
from 6 mice. *P < 0.05 for indicat-
ed values versus young values in 
the same genetic group; †P < 0.05 
for indicated values versus aging 
WT values. Statistical analysis was 
performed using 1-way ANOVA 
followed by Bonferroni’s post hoc 
tests.
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was inhibited by SOD, DPI, Tiron, or l-NAME (Supplemental 
Figure 4). Increased ROS production by human aging brains 
was further confirmed by in situ DHE fluorescence on brain 
sections in the presence or absence of polyethylene glycol–SOD 
(Peg-SOD) (Figure 5B) and MDA assay (Supplemental Figure 5). 
Along with increased ROS production, there were significant 
increases in brain tissue Ang II levels (Figure 5C); upregulation 
of Nox2, downregulation of Nox4, and activation of stress sig-
naling pathways (Figure 5D); and increased phosphorylation of 
p47phox (a key step in Nox2 activation) and MARCKS (a marker 
of PKC activation) (Figure 5E). Immunofluorescence further 
demonstrated that increased Nox2 expression in the aging mid-
brain region was accompanied by significant losses in cerebral 
capillary density (labeled with LE-lectin) and neurons (labeled 
with NeuN) and increased DNA damage (labeled with γH2AX) 
in comparison to young controls (Figure 5F). Our human data 
Experiments using postmortem human midbrain tissues. The 
clinical significance of Nox2 activation in aging-related oxida-
tive damage of human brain microvascular vessels and neu-
rons was examined using postmortem human midbrain tissues 
(including the hippocampus and VTA) of young (25–38 years 
old), middle-aged (45–56 years old), and elderly (61–85 years 
old) adults without diagnosed neurodegenerative diseases, 
obtained from the UK Medical Research Council (MRC) tissue 
bank. The demographics of human brain tissues are shown in 
Supplemental Table 2. It was noted that 5 of 6 middle-aged and 
5 of 8 elderly adults had aging-related metabolic and cardiovas-
cular disorders. There was a significant increase compared with 
young controls in brain O2•– production starting at middle age 
(Supplemental Figure 4) and a further increase (~2-fold) at old 
age, which could be reduced to young control levels by addition 
of Nox2tat (Figure 5A). Increased aging brain O2•– production 
Figure 3. Nox2 subunit expression 
and activation of stress signaling 
pathways in mouse midbrain tissues 
detected by Western blot. (A) Nox 
subunit expression. (B) Phosphoryla-
tion of p47phox and MARCKS. ODs of 
protein bands were quantified and 
normalized to α-tubulin detected 
in the same sample. (C) MAPK 
activation and DNA damage marker 
expression. The phospho-bands 
(P) were quantified and normal-
ized to the total bands (T) of the 
same protein detected in the same 
samples, are expressed as OD P/T. 
The p53 bands were quantified and 
normalized to α-tubulin detected in 
the same sample. n = 6 mice/group. 
*P < 0.05 for indicated values versus 
young values in the same genetic 
group; †P < 0.05 for indicated values 
versus aging WT values. Statistical 
analysis was performed using 1-way 
ANOVA followed by Bonferroni’s post 
hoc tests.
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provided strong support for the discoveries in animals (Figures 
1–4) that Nox2 activation played a key role in oxidative damage 
of cerebral microvasculature and neurons in aging.
Experiments using midbrain tissues of endothelial cell– specific 
expression of human Nox2-transgenic mice at young and middle 
ages. Nox2 is highly expressed in endothelial cells, and the num-
ber of endothelial cells in the brain is similar to that of neurons 
(2). We have found increased brain Ang II levels in aging WT 
mice (Figure 4F) and humans (Figure 5C), and Ang II is a potent 
activator of endothelial Nox2. In order to investigate whether 
endothelial Nox2 activation could trigger whole brain oxidative 
stress and cerebral vasculature rarefaction in aging, we used 
midbrain tissues from middle-aged (11–12 months) HuNox2Tg 
mice. Endothelium-specific overexpression of the human Nox2 
transgene was confirmed by real-time PCR (Supplemental Figure 
6). Endothelial cell–dependent ROS production was confirmed 
by endothelium denudation of HuNox2Tg aortas stimulated 
with Ang II (Supplemental Figure 7). Cerebral endothelial 
(labeled with LE-lectin) expression of human Nox2 mRNA in 
HuNox2Tg brains was confirmed by in situ hybridization using 
RNAscope technology (Supplemental Figure 8).
In comparison to age-matched WT controls, young HuNox2Tg 
brains had slightly higher levels of ROS production (Figure 6A), 
and this was greatly increased at middle age, with levels similar 
to those detected in aging WT brains (Figure 4, A, C, and D), as 
examined by 5 complementary techniques, i.e., lucigenin che-
miluminescence (Figure 6A), SOD-inhibitable cytochrome c 
reduction assay (Figure 6B), Amplex red assay (Figure 6C), in situ 
DHE fluorescence (Figure 6E), and MDA assay (Supplemental 
Figure 9). Increased O2•– production by middle-aged HuNox2Tg 
brains could be markedly inhibited by Nox2tat (Figure 6, A and 
C), which further confirmed a role for Nox2 activation. Increased 
Nox2 protein expression (green) in cerebral endothelium (labeled 
with CD31, red) of HuNox2Tg midbrain sections was further con-
firmed by superposed immunofluorescence (Figure 6D, yellow). 
There was a significant decrease in CD31 immunofluorescence 
in middle-aged huNox2Tg brain sections, suggesting endothelial 
damage (Figure 6D). In comparison to age-matched WT controls, 
Figure 4. Age-associated increases in ROS production and in levels of Ang II and VCAM-1 expression in midbrain tissues of WT and Nox2KO mice. (A) 
ROS production detected by lucigenin chemiluminescence. (B) Inhibitor assay. The effects of different enzyme inhibitors on ROS production by aging WT 
midbrain tissues detected by lucigenin chemiluminescence. #P < 0.05 for indicated values versus aging WT control values without inhibitor. MLU, mean 
light units. (C) Brain tissue lipid peroxidation detected by MDA assay. (D) Brain tissue O2•– production detected by SOD-inhibitable cytochrome c reduction 
assay. (E) Brain tissue H2O2 production detected by catalase-inhibitable Amplex red assay. Nox2tat was used to inhibit Nox2. (F) Brain tissue Ang II levels 
detected by ELISA. (G) Vascular inflammation maker (VCAM-1) expression detected by Western blot analysis. ODs of protein bands were quantified and 
normalized to α-tubulin detected in the same sample. n = 6 mice/group. *P < 0.05 for indicated values versus young values in the same genetic group; †P 
< 0.05 for indicated values versus WT values in the same age group (A, C, D, and F) or for indicated values versus values without inhibitor in the same age 
and genetic group (E). Statistical analysis was performed using 1-way ANOVA followed by Bonferroni’s post hoc tests.
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Figure 5. Nox2 expression, activation of stress signaling pathways, and oxidative damage in postmortem human midbrain tissues. (A) ROS production 
detected by lucigenin chemiluminescence in the presence of an SCP or Nox2tat. (B) ROS production by midbrain sections detected by DHE fluorescence 
with or without Peg-SOD. *P < 0.05 between indicated group values. (C) Brain tissue Ang II levels detected by ELISA. (D) Nox subunit and p53 expression 
and phosphorylation of ERK1/2 and H2AX (to form γH2AX) detected by Western blot analysis. (E) p47phox and MARCKS phosphorylation detected by 
Western blot analysis. ODs of protein bands were quantified and normalized to α-tubulin detected in the same samples. The phospho-ERK1/2 and γH2AX 
bands were normalized to the total protein bands detected in the same samples, expressed as OD P/T. (F) Immunofluorescence on midbrain sections. 
Nox2 was labeled with FITC; cerebral vessels were labeled with LE-lectin (FITC); neurons were labeled with NeuN (Cy3, red); and γH2AX was labeled by Cy3 
(red). Nuclei were labeled with DAPI (blue) to visualize cells. Scale bars: 100 μm. n = 7–8 individual brains and 2 sections/per brain. Fluorescence intensi-
ties were quantified and expressed as percent relative to young (100%). *P < 0.05 for indicated values versus young values (C–F). Statistical analysis was 
performed using 1-way ANOVA followed by Bonferroni’s post hoc tests.
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Figure 6. Nox2 activity and activation of stress signaling pathways in WT and HuNox2Tg mouse midbrain tissues. (A) ROS production detected by 
lucigenin chemiluminescence in the presence of SCP or Nox2tat. (B) O2•– production as detected by SOD-inhibitable cytochrome c reduction assay. (C) H2O2 
production detected by catalase-inhibitable Amplex red assay. (D) Endothelial Nox2 expression. Endothelial cells were labeled with CD31 (red), and Nox2 
was labeled with FITC. Yellow represents endothelial Nox2 expression. (E) ROS production as detected by DHE fluorescence on midbrain sections. (F) 
p47phox and MARCKS phosphorylation. ODs of protein bands were quantified and normalized to α-tubulin detected in the same sample. (G) Brain tissue 
Ang II levels as detected by ELISA. (H) Immunofluorescence detection of phospho-ERK1/2 (red, top row) and γH2AX (red, bottom row). Nuclei were labeled 
with DAPI (blue). Pink indicates the nuclear location of γH2AX. Scale bars: 100 μm. n = 6 mouse brains and 3 sections/per brain. *P < 0.05 for indicated 
values versus young values in the same genetic group; †P < 0.05 for indicated values versus WT values of the same age group; #P < 0.05 for indicated 
values versus values without inhibitor in the same age and genetic group. Statistical analysis was performed using 1-way ANOVA followed by Bonferroni’s 
post hoc tests.
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order to further explore the mechanism of Ang II in cerebral endo-
thelial dysfunction and brain capillary rarefaction in aging, we iso-
lated BMECs from middle-aged WT mice and challenged cells with 
Ang II (100 μM, for 24 hours) in the presence of scrambled control 
peptides (SCPs) or Nox2tat (Figure 7). Compared with vehicle con-
trol, Ang II remarkably increased the levels of BMEC ROS produc-
tion as detected by lucigenin chemiluminescence (Figure 7A) and 
lipid peroxidation as detected by MDA assay (Figure 7B). Increased 
ROS production was accompanied by increased Nox2 expression; 
phosphorylation of p47phox, MARCKS (marker of PKC activation), 
ERK1/2; and increased γH2AX and p53 expression as detected by 
Western blot analysis (Figure 7C). However, all these Ang II–induced 
oxidative responses were inhibited in the presence of Nox2tat. We 
middle-aged HuNox2Tg brains showed significant increases in 
brain Nox2 expression and p47phox phosphorylation as detected 
by Western blot analysis (Figure 6F) and increased brain Ang II 
levels detected by ELISA (Figure 6G). Redox-sensitive ERK1/2 
phosphorylation (Figure 6H top row) and γH2AX formation (a 
marker of DNA damage) were increased in nuclei of middle-aged 
HuNox2Tg brains (Figure 6F, bottom row, pink) in comparison to 
age-matched WT controls.
Experiments using BMECs isolated from middle-aged WT mice. Our 
data from both animals and humans had revealed an age- related 
increase in brain Ang II levels together with Nox2 activation and 
cerebral microvascular damage in aging brains. Ang II is well known 
to cause endothelial dysfunction through the activation of Nox2. In 
Figure 7. Ang II–induced Nox2 activation in mediating cell senescence and capillary damage of BMECs. (A) BMEC O2•– production detected by lucigenin 
chemiluminescence in the presence of SCP or Nox2tat. (B) Lipid peroxidation in BMEC homogenates as detected by MDA assay. (C) Nox2 expression and 
activation of stress signaling pathways as detected by Western blot analysis. ODs of protein bands were quantified and normalized to α-tubulin detected 
in the same samples. The phospho-ERK1/2 and γH2AX bands were normalized to the total protein bands detected in the same samples, expressed as OD 
P/T. (D) Cell senescence and capillary damage. Top row: BMEC senescence as detected by SAβG activity assay (blue). Scale bar: 100 μm. Bottom row: Ang 
II–induced capillary damage on Matrigels. Scale bar: 500 μm. *P < 0.05 for indicated values versus control values in the same treatment group; †P < 0.05 
for indicated values versus Ang II SCP values. n = 4 separate BMEC isolations/group. Three mice were used for each BMEC isolation. Statistical analysis 
was performed using 1-way ANOVA followed by Bonferroni’s post hoc tests.
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secondary peak in activity just before the beginning of the light 
“resting” phase. Although our data suggested that Nox2-derived 
ROS might be involved in the regulation of the circadian rhythm, 
further detailed investigation is required to understand the under-
lying mechanisms.
Cerebral endothelial cells have unique properties in terms 
of blood-brain barrier function, interactions with other types of 
neurovascular cells, and regulation of local blood flow through 
release of signaling molecules (31). Increased cerebral endothe-
lial cell ROS production damages brain vascular homeostasis, 
contributing critically to aging-related neurodegeneration (32). 
By labeling cerebral microvessels using LE-lectin, we showed in 
this study an inverse relationship between increased brain Nox2 
activity and reduced cerebral capillary density in the midbrain 
regions of aging WT mice as well as in elderly humans. Although 
dysfunctional eNOS was also involved in aging brain ROS produc-
tion (inhibited by l-NAME), by using Nox2KO mice, we showed 
that Nox2-derived ROS contributed to a far greater extent to oxi-
dative damage of cerebral vessels and neurons. Nox4 had been 
reported to be implicated in animal models of cerebral ischemia 
and reperfusion injury after stroke (33). In contrast to the acute 
injury model of stroke, aging is a slow process, and there was a 
compensatory increase in Nox4 expression in the aging Nox2KO 
brain. Further detailed study is needed to fully address the role of 
Nox4 in brain aging. The MAPK family is an important signaling 
pathway of Nox2-derived ROS involved in many brain physiolog-
ical and pathological processes, including maintenance of neuro-
nal viability, vascular alteration, and apoptosis (34–37). Increased 
ERK1/2 expression has been found in age-related neurodegener-
ative abnormalities (36). In support of these previous studies, we 
found Nox2-dependent ERK1/2 activation together with a signifi-
cant increase in brain cell DNA damage, i.e., increased γH2AX and 
p53, in the midbrains of aging WT mice and elderly humans.
An important discovery in this study is that increased endothe-
lial cell ROS production due to Nox2 activation can trigger midbrain 
oxidative stress and promote brain cell DNA damage and prema-
ture aging, which has important implications for our current under-
standing and treatment of vascular neurodegenerative disorders. 
Increased endothelial ROS production is a key early characteristic 
component of endothelial dysfunction and is predictive of many 
clinical vascular events (15, 38). By using brain tissues of endothelial 
cell–specific HuNox2Tg mice (14), we demonstrated a substantial 
increase in brain ROS production as early as in middle age, with ROS 
levels equivalent to those detected in aging WT brains. Further-
more, there was significant ERK1/2 activation and DNA damage 
indicated by γH2AX formation in middle-aged HuNox2Tg brains in 
comparison to age-matched WT controls. The clinical significance 
of Nox2-dependent ROS production in human brain aging was fur-
ther demonstrated using postmortem midbrain tissues of young 
(25–38 years old) and elderly (61–85 years old) adults who had 
died of non-neurodegenerative diseases. We demonstrated a clear 
age-related significant increase in Nox2-dependent O2•– production 
in these elderly human brains, which could be markedly inhibited 
by a specific Nox2 inhibitor (Nox2tat) or by Peg-SOD. Once again, 
we showed that accompanying the upregulation of Nox2 were acti-
vation of stress signaling pathways, capillary rarefaction, and loss of 
neuronal density in aging human midbrain tissues.
then examined Ang II–induced endothelial senescence and capillary 
damage. In comparison to control, Ang II increased the numbers 
of senescent cells detected by senescence-associated β-gal (SAβG) 
activity (blue, Figure 7D, top row) and capillary damage on Matrigel 
(Figure 7D, bottom row). However, this Ang II–induced damage to 
BMECs was inhibited in the presence of Nox2tat.
Discussion
The brain is a highly metabolic organ that requires tight regulation 
of its blood perfusion and redox homeostasis for normal function. 
Cumulative brain oxidative stress causes damage to the cerebral 
microvasculature and neurons and is an important pathophysiolog-
ical manifestation in human aging (12, 21). However, the enzymatic 
source and mechanisms (or factors) of excess production of ROS 
in the aging brain remain unclear. This study using age-matched 
littermates of young (3–4 months) and aging (20–22 months) WT 
and Nox2KO mice; brain tissues from endothelial cell–specific 
huNox2Tg mice; and postmortem human midbrain tissues at ages of 
25–38 years versus 61–85 years demonstrated that (i) brain oxidative 
stress attributable to the activation of Nox2-NADPH oxidase plays a 
key role in aging-related cerebral capillary rarefaction, loss of neu-
rons, and locomotor dysfunction; and (ii) increased endothelial cell 
ROS production due to endothelial Nox2 overexpression can trigger 
brain oxidative stress and DNA damage as early as in middle age.
Aging is associated with metabolic disorders and decreased 
control in locomotor function and increases the risk of devel-
oping neurodegenerative diseases. NADPH oxidase is highly 
expressed in brain cells including cerebral endothelial cells and 
is involved in the regulation of brain function by generating ROS 
(22–24). Long-term physical inactivity has been shown to acti-
vate endothelial NADPH oxidase, resulting in cerebral vascular 
dysfunction in mice (25). On the other hand, routine locomo-
tor activity reduces brain oxidative stress (26). Adding to this 
knowledge about redox regulation of brain function, the current 
study showed that the normal aging process is associated with 
a massive increase in brain Nox2-dependent ROS production, 
together with a reduction in locomotor function, including vol-
untary wheel running activity in aging WT but not Nox2KO mice.
Voluntary wheel running is not only a general spontaneous 
aerobic exercise for mice but also reflects several underlying 
behavioral processes, including motivation (27). Dopaminergic 
neurons in the VTA are important for cognition, motivation, and 
control of locomotor activity (28). Reduced dopaminergic neuron 
firing capability is involved in aging-related behavior disorders, 
including impaired motor activity and loss of motivation of vol-
untary exercise (19, 29). Inhibition of Nox2 enzyme or knockout 
of p47phox (a key regulatory subunit of NADPH oxidase) protected 
dopaminergic neurons from degeneration and improved behavior 
and locomotor activity (23, 30). In accordance with these previ-
ous studies, we found an aging-related loss of neurons and dam-
age to the dopaminergic neuronal electrophysiological properties 
of aging WT mice. In stark contrast, knocking out Nox2 protected 
neurons from oxidative damage and preserved dopaminergic neu-
ron firing function in aging. Our data strongly suggest a crucial role 
for Nox2-derived ROS in aging-related loss of brain function. The 
diurnal rhythm of locomotor activity was present in all groups of 
mice. However, aging WT mice (but not Nox2KO mice) lost the 
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conscious mice (after 1 week of training) at 10 am, and measurements 
were recorded by the CODA program. Serum glucose was measured at 
9 am after 8 hours of fasting using a blood glucose meter (Accu-Chek). 
Fasting plasma insulin was measured using a mouse insulin ELISA kit 
(Mercodia). Fasting serum cholesterol and HDL cholesterol were mea-
sured by enzymatic colorimetric assays using an ILab 650 Chemistry 
System (Instrumentation Laboratory). LDL cholesterol was calculated 
as the difference between total and HDL cholesterol concentrations 
based on the Friedewald equation (42).
Locomotor activity measurement. Mice were housed individually 
in motility chambers (Linton Instrumentation) at 18–23°C and 45%–
55% humidity with a 12-hour-light/12 hour-dark cycle, and food and 
water were available ad libitum. The horizontal and vertical activi-
ties of the mice were measured using 2 sets of 16 photocells located 
at right angles to each other, projecting horizontal infrared beams 2.5 
cm apart and 1 and 6 cm above the cage floor. The lower beams at 1 
cm measured horizontal activity, and the upper beams at 6 cm mea-
sured vertical, rearing activity. Activities were measured as sequential 
infrared beam breaks and recorded in 30-minute bins for 42 hours on 
AmonLite activity monitoring software (MJS Technology Ltd.). For 
the voluntary wheel running activities, mice were housed individually 
with open access to a running wheel mounted in the cage (ClockLab, 
ActiMetrics). Running wheel activities in 2-minute bins for a period of 
10 days were recorded using passive infrared (PIR) detection (RISCO 
Ltd.) and analyzed using ClockLab software.
Dopaminergic neuron firing by extracellular electrophysiology. 
The extracellular electrophysiology experiments were performed as 
described previously (43). Coronal slices (300 μm) containing the 
substantia nigra and VTA were prepared using a vibratome (VT1200, 
Leica) in ice-cold oxygenated electrophysiology buffer containing 123 
mM NaCl, 22 mM NaHCO3, 1.25 mM NaH2PO4, 3.75 mM KCl, 10 mM 
d-glucose, 2.5 mM CaCl2, and 1.2 mM MgSO4. Single-cell extracellular 
recordings using glass microelectrodes filled with buffer (impedance 
of 3–6 MΩ) were captured using an Axopatch 1D (Axon Instruments) 
in I = 0 mode with a low cutoff frequency of 2 kHz and then further 
amplified by 100 times in the AC mode using a Neurolog system (Digi-
data) without any further filtering. Signals were then digitized using 
a CED 1401 plus (Cambridge) and captured using Spike2 software. 
Dopaminergic neurons in the VTA were distinguished by a firing fre-
quency of 0.5–4 Hz, an action potential waveform of approximately 
2.5–3 ms in duration, and inhibition of firing in response to 50 μM 
dopamine perfusion. A baseline firing frequency was recorded for 
5–10 minutes. AMPA (0.5 μM) was then perfused and recorded for 
approximately 6 minutes. The AMPA was then washed out, and firing 
frequency was left to return to its basal rate. After 10–15 minutes, 50 
μM dopamine was perfused, which blunted dopaminergic neuron fir-
ing. The dopamine was washed out to allow firing to return to normal, 
which ensured that the blunting of the signal was due to the dopamine 
perfusion. The results were analyzed manually using Spike2 software.
Mouse BMEC isolation. BMECs were isolated from the brains of 
middle-aged (11–12 months) WT mice according to a protocol published 
previously, with some modifications (44). Briefly, brain tissues (n = 3) 
were cut into pieces (2 mm3) and digested in a 50-mL Falcon tube with 
6 mL digestion buffer containing Liberase Blendzyme (0.1 U/mL) and 
DNAse (1 μg/mL) for 8 minutes at 37°C while shearing through the bore 
of a 10-mL pipette every 3 minutes. At the end of digestion, the super-
natant containing cells and microvessels was transferred into a new 
All components of the renin-angiotensin system are present 
within the CNS, and local production of brain Ang II is now well 
accepted to contribute to the development of hypertension at 
old age (39, 40). Ang II has been established as a potent activa-
tor of endothelial Nox2. In this study, we found a close relation-
ship between brain tissue levels of Ang II and Nox2-derived ROS 
for both mice and humans. Using primary BMECs isolated from 
middle- aged WT mice, we further showed that in response to Ang 
II stimulation, BMECs showed a significant, 3-fold increase in 
ROS production, and this was accompanied by significant Nox2 
activation, cell senescence, and capillary damage on Matrigels. 
However, the Ang II–induced endothelial damage was reduced in 
the presence of Nox2tat.
In conclusion, by using several complementary approaches 
(including in vivo whole animal pathophysiology and in vitro BMEC 
culture; comparing WT mice with Nox2KO and HuNox2TG mice; 
and comparing human postmortem brain tissues of young and 
elderly adults), our study provides insight into the mechanisms by 
which Nox2-derived ROS regulates brain aging. Increased endo-
thelial Nox2–derived ROS production possibly plays a key role in 
triggering brain oxidative stress, DNA damage, and brain aging. 
These findings have important implications for our understanding 
and management of vascular neurodegenerative disorders.
Methods
Reagents. Details of primary and secondary antibodies used in this study 
are shown in Supplemental Table 1. DHE was from Invitrogen. The SCP 
and Nox2tat ([H]-RKKRRQRRRCSTRVRRQL-[NH2]) were provided 
by PeptideSynthetics (Peptide Protein Research Ltd.). All other reagents 
and chemicals were from Sigma-Aldrich unless otherwise stated
Animals. Nox2KO mice on a C57BL/6J background were originally 
obtained from the Jackson Laboratory. Nox2KO mice lack phagocyte 
superoxide production and manifest an increased susceptibility to 
infection. Littermates of WT and Nox2KO mice were bred at the Uni-
versity of Surrey from heterozygotes and genotyped. Animals were 
housed under standard conditions with a 12-hour-light/12-hour dark 
cycle, and food and water were available ad libitum. Male mice were 
randomly grouped (n = 10–12/per group) and used at young age (3–4 
months), middle age (11–12 months), and old age (20–22 months) 
for the experiments. Endothelial cell–specific expression (under the 
murine Tie2 promoter) of human Nox2-transgenic (HuNox2Tg) mice 
was generated in the laboratory of Keith Channon (Oxford University) 
as described previously (14). Brain tissues obtained from littermates of 
age-matched WT and HuNox2Tg mice at young (3–4 months) and mid-
dle age (11–12 months) (n = 6/per group) were used for the experiments.
Human midbrain tissue collection. Postmortem human midbrain 
tissues from males and females who died of non-neurodegenerative 
diseases were obtained from the UK MRC Edinburgh Brain and Tissue 
Bank headed by Colin Smith (University of Edinburgh). Samples from 
midbrain regions (including the hippocampus and VTA) without gross 
pathological abnormalities were collected and grouped randomly 
according to age: young adult (25–38 years, n = 7); middle-aged (45–56 
years, n = 6); and elderly (61–85 years, n = 8). Demographics of human 
brain tissues are shown in Supplemental Table 2.
Metabolic assessments. Metabolic assessments were performed 
as described previously (4, 41). BP was measured by a computer- 
controlled noninvasive tail-cuff BP system (Kent Scientific Corp.) on 
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Immunofluorescence microscopy. Immunofluorescence microscopy 
experiments were performed exactly as described previously (4, 41). 
Primary antibodies were used at 1:250 dilution. BSA (2%) was used in 
place of primary antibodies as a negative control. Biotin-conjugated anti- 
rabbit or anti-goat IgG (1:1000 dilution) were used as secondary anti-
body. Specific binding of antibodies was detected by ExtrAvidin- FITC 
or streptavidin-Cy3. Images were acquired with either an Olympus BX61 
fluorescence microscope system or a Zeiss fluorescence microscope sys-
tem (Axio Scope.A1). Fluorescence intensities were quantified digitally.
Detection of brain tissue Ang II and MDA assay. Ang II levels and 
lipid peroxidation were detected in the midbrain tissue homogenates 
using an Ang II EIA kit and an MDA assay kit, respectively (Sigma- 
Aldrich) according to the manufacturer’s instructions.
Statistics. Statistical analysis was performed using 1-way ANO-
VA followed by Bonferroni’s post hoc tests, except where otherwise 
specified in the figure legends. Animal metabolic data were obtained 
from at least 9 mice/group. For the human study, 7–8 individual 
brain samples were used in each group. Data are presented as box 
(first and third quartiles) and whiskers (maximum and minimum). 
The line in the box represents the median. For data not presented as 
box and whiskers, mean ± SD was used. P values less than 0.05 were 
considered statistically significant.
Study approval. The animal studies were performed under the 
Home Office animal work project licence (PPL 70/6729 and PPL 
70/7638) in accordance with protocols approved by both the Ethics 
Committee of the University of Surrey and the Home Office under 
the Animals (Scientific Procedures) Act 1986, United Kingdom. The 
postmortem human brain tissues were obtained from the UK MRC 
Edinburgh Brain and Tissue Bank. This study received ethical approv-
al from the UK National Health Service Research Ethical Committee 
(East of Scotland Ethics Service) and the Ethics Committee of the 
University of Edinburgh.
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tube containing 1 mL ice-cold FCS to stop the digestion. The digestion 
was repeated 4 times until no visible tissue pieces were left in the tube. 
Tubes were spun at 120 g for 10 minutes. The supernatant containing 
myelin was discarded, and the pellets were titrated through a 21-gauge 
needle 3 times. After washing, BMECs were cultured in flasks coated 
with collagen type I. BMECs were cultured in the DMEM/Nutrient 
Mixture F-12 medium supplemented with 10% FBS, EC growth supple-
ment (30 μg/mL), EGF (10 ng/mL), VEGF (0.5 ng/mL), ascorbic acid 
(1 μg/mL), hydrocortisone (1 μg/mL), l-glutamine (2 mM), penicillin 
(50 U/mL), and streptomycin (50 μg/mL). BMECs were cultured for 
3–4 weeks before being used for experiments.
In situ detection of SAβG activity. Activity of SAβG (a cell senescence 
marker) in cultured BMECs was performed as described previously (45). 
Briefly, cells were cultured on chamber slides and treated according to 
the experimental design. After fixation with 1% ice-cold paraformalde-
hyde and washing in PBS, cells were incubated with freshly prepared 
staining buffer containing 40 mM citric acid/sodium (pH 6.0), 0.15 M 
NaCl, 2 M MgCl2, 5 mM potassium ferrocyanide, and 1 mg/mL X-gal 
(5-bromo-4-chloro-3-indolyl β-d-galactopyranoside). SAβG-positive 
cells (blue) were examined microscopically and counted.
Capillary tube formation on Matrigels. Study of capillary tube forma-
tion on Matrigels was performed according to a previously published 
method (46). Matrigel was purchased from Sigma-Aldrich (E6909, 
ECM Gel) and prepared according to the manufacturer’s instructions. 
Soluble Matrigel (100 μL) was then added using precooled tips into 
a 48-well plate to cover the wells evenly. BMECs (5 × 103/well) were 
then seeded into the wells and cultured in complete growth medium 
overnight. The following morning, cells were treated according to the 
experimental conditions for 48 hours. The rings per well was counted, 
and cells were photographed under phase-contrast microscopy.
ROS measurement. ROS production by brain (or cerebral endothe-
lial cell) homogenates was measured using 3 complementary tech-
niques (47): (i) lucigenin (5 μM) chemiluminescence in tissue homog-
enates detected using a 96-well microplate luminometer (Molecular 
Devices); (ii) detection of in situ DHE (2 μM) fluorescence on tissue 
sections in the presence or absence of Tiron (10 mM, a nonenzymatic 
O2•– scavenger) to confirm the detection of O2•– using a Zeiss fluores-
cence microscope and quantified from at least 5 random fields/section 
with 3 sections/sample and 6 animals/group; and (iii) SOD (200 U/
mL)–inhibitable cytochrome c reduction assay. The enzymatic sources 
of ROS production were further examined using inhibitors targeting 
NOS (l-NAME, 100 μM), the mitochondrial complex I enzymes (rote-
none, 50 μM), xanthine oxidase (oxypurinol, 250 μM), flavoproteins 
(DPI, 20 μM), or Nox2 (peptide inhibitor Nox2tat, 10 μM), or an SCP 
(10 μM). SOD (200 U/mL) was used to confirm the detection of O2•–.
Immunoblotting. Immunoblotting was performed exactly as 
described previously (41). Midbrain tissue homogenates were used for 
immunoblotting. For BMEC experiments, cell homogenates were used 
for immunoblotting. The images were captured digitally using a Bio-
Spectrum AC imaging system (UVP), and the optical densities of the pro-
tein bands were normalized to the loading control bands and quantified.
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